(CRM) Salesforce.com - Overview
Sector: Technology | Industry: Software - Application | Exchange: NYSE (USA) | Market Cap: 174.507m USD | Total Return: -26.2% in 12m
Avg Trading Vol: 2.25B USD
Peers RS (IBD): 47.3
EPS Trend: 89.5%
Qual. Beats: 3
Rev. Trend: 98.4%
Qual. Beats: 0
Salesforce (NYSE: CRM) delivers a comprehensive suite of cloud-based CRM solutions, ranging from the Agentforce AI layer and Data Cloud engine to Slack, Tableau, and industry-specific AI agents. Its portfolio also includes Salesforce Starter for SMBs, commerce services, and field-service tools that unify sales, service, and marketing workflows on a single platform.
In FY 2025 the company posted $31.4 billion in revenue, a 12% year-over-year increase, with subscription-and-support revenue reaching $27.1 billion and operating cash flow of $6.2 billion. Adoption of its Data Cloud and AI-driven features grew roughly 45% YoY, reflecting broader enterprise spending on AI-enabled software, which the IDC forecasts will expand at a 9% annual rate through 2027.
For a deeper dive, you might explore ValueRay’s analyst notes on CRM.
- Cloud software demand drives subscription revenue growth
- AI integration expands platform capabilities and market share
- Enterprise spending trends impact new license sales
- Competition from Microsoft and Oracle pressures pricing
- Economic slowdowns reduce customer acquisition and expansion
| Net Income: 7.46b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 0.74 > 1.0 |
| NWC/Revenue: -21.42% < 20% (prev 4.61%; Δ -26.03% < -1%) |
| CFO/TA 0.13 > 3% & CFO 15.00b > Net Income 7.46b |
| Net Debt (9.85b) to EBITDA (12.72b): 0.77 < 3 |
| Current Ratio: 0.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (940.0m) vs 12m ago -3.49% < -2% |
| Gross Margin: 77.68% > 18% (prev 0.77%; Δ 7.69k% > 0.5%) |
| Asset Turnover: 38.59% > 50% (prev 36.82%; Δ 1.77% > 0%) |
| Interest Coverage Ratio: 45.02 > 6 (EBITDA TTM 12.72b / Interest Expense TTM 202.0m) |
| A: -0.08 (Total Current Assets 28.22b - Total Current Liabilities 37.12b) / Total Assets 112.31b |
| B: 0.20 (Retained Earnings 22.22b / Total Assets 112.31b) |
| C: 0.08 (EBIT TTM 9.09b / Avg Total Assets 107.62b) |
| D: 0.42 (Book Value of Equity 22.54b / Total Liabilities 53.16b) |
| Altman-Z'' Score: 1.14 = BB |
| DSRI: 1.10 (Receivables 14.34b/11.95b, Revenue 41.52b/37.90b) |
| GMI: 0.99 (GM 77.68% / 77.19%) |
| AQI: 1.07 (AQ_t 0.70 / AQ_t-1 0.66) |
| SGI: 1.10 (Revenue 41.52b / 37.90b) |
| TATA: -0.07 (NI 7.46b - CFO 15.00b) / TA 112.31b) |
| Beneish M-Score: -2.91 (Cap -4..+1) = A |
Over the past week, the price has changed by +4.39%, over one month by -4.52%, over three months by -26.96% and over the past year by -26.18%.
- StrongBuy: 28
- Buy: 13
- Hold: 12
- Sell: 2
- StrongSell: 0
| Wallstreet Target Price | 273.1 | 46.3% |
| Analysts Target Price | 273.1 | 46.3% |
P/E Forward = 14.1443
P/S = 4.2025
P/B = 2.9066
P/EG = 1.0105
Revenue TTM = 41.52b USD
EBIT TTM = 9.09b USD
EBITDA TTM = 12.72b USD
Long Term Debt = 10.44b USD (from longTermDebt, last quarter)
Short Term Debt = 4.55b USD (from shortTermDebt, last quarter)
Debt = 17.18b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.85b USD (from netDebt column, last quarter)
Enterprise Value = 182.12b USD (174.51b + Debt 17.18b - CCE 9.56b)
Interest Coverage Ratio = 45.02 (Ebit TTM 9.09b / Interest Expense TTM 202.0m)
EV/FCF = 12.65x (Enterprise Value 182.12b / FCF TTM 14.40b)
FCF Yield = 7.91% (FCF TTM 14.40b / Enterprise Value 182.12b)
FCF Margin = 34.68% (FCF TTM 14.40b / Revenue TTM 41.52b)
Net Margin = 17.96% (Net Income TTM 7.46b / Revenue TTM 41.52b)
Gross Margin = 77.68% ((Revenue TTM 41.52b - Cost of Revenue TTM 9.27b) / Revenue TTM)
Gross Margin QoQ = 77.61% (prev 78.02%)
Tobins Q-Ratio = 1.62 (Enterprise Value 182.12b / Total Assets 112.31b)
Interest Expense / Debt = 0.39% (Interest Expense 67.0m / Debt 17.18b)
Taxrate = 26.07% (685.0m / 2.63b)
NOPAT = 6.72b (EBIT 9.09b * (1 - 26.07%))
Current Ratio = 0.76 (Total Current Assets 28.22b / Total Current Liabilities 37.12b)
Debt / Equity = 0.29 (Debt 17.18b / totalStockholderEquity, last quarter 59.14b)
Debt / EBITDA = 0.77 (Net Debt 9.85b / EBITDA 12.72b)
Debt / FCF = 0.68 (Net Debt 9.85b / FCF TTM 14.40b)
Total Stockholder Equity = 60.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.93% (Net Income 7.46b / Total Assets 112.31b)
RoE = 12.37% (Net Income TTM 7.46b / Total Stockholder Equity 60.29b)
RoCE = 12.86% (EBIT 9.09b / Capital Employed (Equity 60.29b + L.T.Debt 10.44b))
RoIC = 9.57% (NOPAT 6.72b / Invested Capital 70.23b)
WACC = 9.05% (E(174.51b)/V(191.68b) * Re(9.91%) + D(17.18b)/V(191.68b) * Rd(0.39%) * (1-Tc(0.26)))
Discount Rate = 9.91% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.81%
[DCF] Terminal Value 78.25% ; FCFF base≈13.61b ; Y1≈16.80b ; Y5≈28.66b
[DCF] Fair Price = 427.6 (EV 404.48b - Net Debt 9.85b = Equity 394.64b / Shares 923.0m; r=9.05% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 89.47 | EPS CAGR: 43.63% | SUE: 4.0 | # QB: 3
Revenue Correlation: 98.37 | Revenue CAGR: 11.64% | SUE: 0.56 | # QB: 0
EPS next Quarter (2026-07-31): EPS=3.24 | Chg7d=+0.003 | Chg30d=+0.004 | Revisions Net=+0 | Analysts=39
EPS current Year (2027-01-31): EPS=13.20 | Chg7d=+0.008 | Chg30d=+0.038 | Revisions Net=-1 | Growth EPS=+5.4% | Growth Revenue=+11.1%
EPS next Year (2028-01-31): EPS=14.89 | Chg7d=-0.018 | Chg30d=+0.021 | Revisions Net=+0 | Growth EPS=+12.8% | Growth Revenue=+9.5%
[Analyst] Revisions Ratio: +0.00 (19 Up / 19 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.7% (Discount Rate 9.9% - Earnings Yield 4.2%)
[Growth] Growth Spread = +5.1% (Analyst 10.8% - Implied 5.7%)